Sickle Cell Treatment Not Linked to Cancer, Researchers Say - The New York Times - 0 views
-
Like Bluebird Bio’s investigators, Dr. Williams and his colleagues are using a disabled lentivirus to deliver a gene to sickle cell patients. Lentiviruses are thought to be safe — hundreds of patients in other gene therapy trials have been treated with them, and no blood cancers were reported. The possibility that lentiviruses might not be safe was of grave concern.
-
“These data indeed point away from the vector as causative,” he wrote in an email. But, he added, researchers still need to better understand the illnesses in the trial participants before they can breathe a final sigh of relief.